急性心肌梗死合并心原性休克患者主动脉内球囊反搏支持下行急诊经皮冠状动脉介入治疗的临床疗效观察Clinical efficacy of intra-aortic balloon pump in the emergency percutaneous coronary intervention treatment of patients with acute myocardial infarction combined with cardiogenic shock
胡昊,吴佳纬,李丹,余晓凡,李龙伟,余东彪,孔祥勇,华锦胜,周俊岭,陈鸿武,冯克福,余华,马礼坤
摘要(Abstract):
目的探讨主动脉内球囊反搏(IABP)在急性心肌梗死(AMI)合并心原性休克(CS)患者中的疗效及影响死亡率的危险因素。方法连续纳入2014年1月至2017年12月中国科技大学附属第一医院因AMI合并CS急诊置入IABP并行经皮冠状动脉介入治疗(PCI)的患者291例。根据住院期间是否死亡分为死亡组63例(21.6%)和存活组228例(78.4%),分析两组患者临床资料、实验室检查结果及术中并发症等。结果死亡患者年龄[(75.3±11.6)岁比(67.5±12.2)岁,P<0.001],糖尿病(63.5%比34.6%,P<0.001)、既往PCI史(4.8%比0.4%,P=0.033)、心房颤动(11.1%比0.9%,P<0.001)、左心室射血分数(LVEF)≤40%(74.6%比19.7%,P<0.001)、左主干病变(15.9%比1.3%,P<0.001)、血小板减少(4.8%比0.9%,P=0.017)比例及首次医疗接触至球囊扩张(FMC-to-B)时间[(11.18±3.63)h比(4.74±1.91)h,P<0.001]均显著高于存活组,差异均有统计学意义。logistic多因素回归分析发现,FMC-to-B时间(OR 2.291,95%CI 1.712~3.067,P<0.001)、LVEF(OR 0.909,95%CI 0.854~0.967,P=0.003)和PCI术后靶血管心肌梗死溶栓治疗试验(TIMI)血流分级≤Ⅱ级(OR28.329,95%CI 6.752~118.864,P<0.001)为死亡率的独立影响因素。结论 IABP是对AMI合并CS患者目前最常用的机械循环辅助救治手段,PCI术后靶血管TIMI血流分级≤Ⅱ级、LVEF以及FMC-to-B时间是预测患者死亡率的独立影响因素。
关键词(KeyWords): 主动脉内球囊反搏;急性心肌梗死;心原性休克;药物支架置入
基金项目(Foundation): 安徽省公益性技术应用研究联动计划(15011d04032);; 安徽省科技攻关计划(1604a0802074)
作者(Author): 胡昊,吴佳纬,李丹,余晓凡,李龙伟,余东彪,孔祥勇,华锦胜,周俊岭,陈鸿武,冯克福,余华,马礼坤
参考文献(References):
- [1]Levine GN,Bates ER,Blankenship JC,et al.2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction:an update of the 2011 ACCF/AHA/SCAI Guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction.J Am Coll Cardiol,2016,67(10):1235-1250.
- [2]De Felice F,Guerra E,Fiorilli R,et al.One-year clinical outcome of elderly patients undergoing angioplasty for ST-elevation myocardial infarction complicated by cardiogenic shock:the importance of3-vessel disease and final TIMI-3 flow grade.J Invasive Cardiol,2014,26(3):114-118.
- [3]Schuster A,Faulkner M,Zeymer U,et al.Economic implications of intra-aortic balloon support for myocardial infarction with cardiogenic shock:an analysis from the IABP-SHOCK II-trial.Clin Res Cardiol,2015,104,(7):566-573.
- [4]Hochman JS,Sleeper LA,Webb JG,et al.Early revascularization inacute myocardial infarction complicated by cardiogenic shock.SHOCK investigators.Should we emergently revascularize occluded coronaries for cardiogenic shock.N Engl J Med,1999,341(9):625-634.
- [5]Babaev A,Frederick PD,Pasta DJ,et al.Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock.JAMA,2005,294(4):448-454.
- [6]Goldberg RJ,Spencer FA,Gore JM,et al.Thirty-year trends(1975 to 2005)in themagnitude of,management of,and hospital death rates associated with cardiogenic shock in patientswith acute myocardial infarction:a population-based perspective.Circulation.2009,119(9):1211-1219.
- [7]P?ss J,K?ster J,Fuernau G,et al.Risk stratification for patients in cardiogenic Shock after acute myocardial infarction.J Am Coll Cardiol,2017,69(15):1913-1920.
- [8]中华医学会心血管病学分会介入心脏病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,中华心血管病杂志编辑委员会.中国经皮冠状动脉介入治疗指南(2016).中华心血管病学杂志,2016,44(5):382-400.
- [9]Atkinson TM,OhmanEM,O'NeillWW,et al.A practical approach to mechanical circulatory support in patients undergoing percutaneous coronary intervention:an interventional perspective.JACCCardiovasc Interv,2016,9(9):871-883.
- [10]Lee JM,Rhee TM,Hahn JY,et al.Multivesselpercutaneous coronary intervention in patients with st segment elevation myocardial infarction with cardiogenic shock.J Am Coll Cardiol,2018,71(8):844-856.
- [11]White HD,Assmann SF,Sanborn TA,et al.Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock:results from the should we emergently revascularize occluded coronaries for cardiogenic shock(SHOCK)trial.Circulation,2005,112(13):1992-2001.
- [12]Sheu JJ,Tsai TH,Lee FY,et al.Earlyextracorporeal membrane oxygenator-assisted primary percutaneouscoronary intervention improved 30-day clinical outcomes in patientswith ST-segment elevation myocardial infarction complicated withprofound cardiogenic shock.Crit Care Med,2010,38(9):1810-1817.
- [13]吴铿,游琼,郑锡锋,等.经肱动脉与经股动脉路径进行主动脉内球囊反搏术治疗急性心肌梗死合并心源性休克患者的对比研究.中国介入心脏病学杂志,2014,22(2):106-110.
- [14]宋莉,颜红兵,王健,等.主动脉内球囊反搏术在急性心肌梗死治疗中的应用和对近期预后的影响.中国介入心脏病学杂志,2009,17(1):5-8.
- [15]Thiele H,Sick P,Boudriot E,et al.Randomized comparison of intra-aorticbaloon support with a percutaneous left ventricular assist device inpatients with revascularized acute myocardial infarction complicatedby cardiogenic shock.Eur Heart J,2005,26(13):1276-1283.
- [16]Thiele H,Akin I,Sandri M,et al.PCI strategies in patients with acute myocardial infarction and cardiogenic shock.N Engl J Med,2017,377(25):2419-2432.
- [17]Chung ES,Lim C,Lee HY,et al.Results ofextracorporeal membrane oxygenation(ECMO)support beforecoronary reperfusion in cardiogenic shock with acute myocardialinfarction.Korean J Thorac Cardiovasc Surg,2011,44(4):273-278.